Intersect ENT, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1.9M | 29,858 | 26.4% |
| Unspecified | $1.6M | 412 | 22.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.3M | 350 | 18.5% |
| Travel and Lodging | $908,013 | 2,846 | 12.8% |
| Consulting Fee | $727,618 | 752 | 10.2% |
| Current or prospective ownership or investment interest | $611,498 | 10 | 8.6% |
| Education | $55,639 | 24 | 0.8% |
| Grant | $2,000 | 2 | 0.0% |
| Charitable Contribution | $1,890 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| EXPAND | $615,738 | 3 | 94 |
| ASCEND | $443,715 | 4 | 99 |
| ENCORE | $344,480 | 1 | 124 |
| FRONTIER | $103,699 | 3 | 63 |
| RESOLVE II | $23,265 | 2 | 19 |
| PIO III | $23,000 | 0 | 2 |
| PROGRESS | $22,578 | 1 | 3 |
| PIO II | $10,100 | 1 | 2 |
| Resolve II | $7,500 | 1 | 5 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Frederic Moll, M.d, M.D | General Practice | Redwood City, CA | $646,915 | $0 |
| Dr. James Kallman, Md, MD | Facial Plastic Surgery | Anchorage, AK | $287,052 | $0 |
| Dr. Jose Stolovitzky, M.d, M.D | Otolaryngology | Atlanta, GA | $258,791 | $0 |
| David Conley, Md, MD | Otolaryngology | Chicago, IL | $252,413 | $0 |
| Dr. Greg Davis, Md, Mph, MD, MPH | Otolaryngology | Puyallup, WA | $251,703 | $0 |
| Dr. Troy Woodard, M.d, M.D | Otolaryngology | Buffalo, NY | $117,927 | $0 |
| Keith Matheny, M.d, M.D | Otolaryngology | Frisco, TX | $103,199 | $0 |
| Boris Karanfilov, Md, MD | Otolaryngology | Dublin, OH | $93,818 | $0 |
| Dr. Roheen Raithatha, M.d, M.D | Facial Plastic Surgery | New York, NY | $90,342 | $0 |
| Dr. Jeb Justice, Md, MD | Otolaryngology | Gainesville, FL | $88,301 | $0 |
| Martin Citardi, Md, MD | Otolaryngology | Houston, TX | $74,874 | $0 |
| Brent O'connell, M.d, M.D | Pediatrics | Harrisburg, PA | $70,250 | $0 |
| Dr. Ameet Singh, M.d, M.D | Otolaryngology | Washington, DC | $69,090 | $0 |
| Dr. Sanjeet Rangarajan, M.d, M.D | Otolaryngology | Cleveland, OH | $54,900 | $0 |
| Jivianne Lee, Md, MD | Plastic Surgery within the Head & Neck | Santa Monica, CA | $48,266 | $0 |
| Dr. Ian Humphreys, D.o, D.O | Otolaryngology | Seattle, WA | $44,640 | $0 |
| David Yen, M.d, M.D | Specialist | Bethlehem, PA | $42,621 | $0 |
| Paul Yun, Md, MD | Otolaryngology | Menlo Park, CA | $42,520 | $0 |
| Kevin Mclaughlin, M.d, M.D | Otolaryngology | Covington, LA | $40,663 | $0 |
| Mr. Adil Fatakia, M.d, M.D | Otolaryngology | Marrero, LA | $40,212 | $0 |
| Louis Portugal | Otolaryngology | Chicago, IL | $39,976 | $0 |
| Mr. Rajiv Pandit, M.d, M.D | Specialist | Dallas, TX | $38,383 | $0 |
| Dr. Naveen Bhandarkar, M.d, M.D | Otolaryngology | Orange, CA | $34,894 | $0 |
| Dr. Joseph Han, Md, MD | Otolaryngology | Norfolk, VA | $32,306 | $0 |
| Dr. Nipun Chhabra, M.d, M.D | Otolaryngology | Leesburg, VA | $31,225 | $0 |
Top Products
- PROPEL $2.8M
- SINUVA $1.1M
Associated Products (4)
- PROPEL $3.8M
- SINUVA $1.1M
- No Product $654,176
- VenSure $20,147
Payment Categories
- Food & Beverage $1.9M
- Consulting $727,618
- Travel & Lodging $908,013
- Research $1.6M
About Intersect ENT, Inc.
Intersect ENT, Inc. has made $7.1M in payments to 7,040 healthcare providers, recorded across 34,255 transactions in the CMS Open Payments database. In 2022, the company paid $445,370. The top product by payment volume is PROPEL ($2.8M).
Payments were distributed across 118 medical specialties. The top specialty by payment amount is Otolaryngology ($3.7M to 4,012 doctors).
Payment categories include: Food & Beverage ($1.9M), Consulting ($727,618), Research ($1.6M), Travel & Lodging ($908,013).
Intersect ENT, Inc. is associated with 4 products in the CMS Open Payments database, including PROPEL, SINUVA, and No Product.